These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 5569952

  • 1. [One year of experience with L-Dopa in Parkinson's disease].
    Henry P, Lacut JY, Pouget-Abadie J, Bergouignan M, Leng-Lĕvy J.
    Bord Med; 1971 May; 4(5):1581-91. PubMed ID: 5569952
    [No Abstract] [Full Text] [Related]

  • 2. L-Dopa therapy in Parkinson's disease (a year's experience with 20 patients).
    Fincham RW, Decker DA.
    J Iowa Med Soc; 1970 Nov; 60(11):755-9. PubMed ID: 5482403
    [No Abstract] [Full Text] [Related]

  • 3. [Our experience with the treatment of Parkinson's disease with L-dopa].
    Buscaino GA, Campanella G.
    Acta Neurol (Napoli); 1971 Nov; 26(1):46-60. PubMed ID: 5553941
    [No Abstract] [Full Text] [Related]

  • 4. [Therapy of Parkinson's syndrome with L-dopa per os combined with a decarboxylase inhibitor (Ro 46.02)].
    Tissot R, Gaillard JM, Guggisberg M, Gauthier G, De Ajuriaguerra J.
    Neurol Neurocir Psiquiatr; 1969 Nov; 10(1):1-25. PubMed ID: 5406970
    [No Abstract] [Full Text] [Related]

  • 5. [L-Dopa in the treatment of Parkinson's disease].
    Warot P.
    Lille Med; 1971 Nov; 17():Suppl:329-34. PubMed ID: 5153001
    [No Abstract] [Full Text] [Related]

  • 6. L-dopa induced dyskinesias in 152 patients with Parkinson's disease.
    Mones RJ, Elizan TS, Siegel G.
    Trans Am Neurol Assoc; 1970 Nov; 95():286-7. PubMed ID: 5514393
    [No Abstract] [Full Text] [Related]

  • 7. L-Dopa therapy of Parkinson's disease. (A review of the preliminary experience at West Virginia University).
    Gutmann L, Martin JD, Gutrecht JA.
    W V Med J; 1970 Apr; 66(4):109-11. PubMed ID: 5264660
    [No Abstract] [Full Text] [Related]

  • 8. Parkinson's disease treated with L-dopa. Three-year follow-up report.
    Mones RJ.
    N Y State J Med; 1972 Nov 15; 72(22):2749-50. PubMed ID: 4510706
    [No Abstract] [Full Text] [Related]

  • 9. [L-dopa and Parkinson's disease].
    Barbeau A.
    Union Med Can; 1970 Dec 15; 99(12):2195-7. PubMed ID: 5488646
    [No Abstract] [Full Text] [Related]

  • 10. An analysis of L-dopa-induced dyskinesias in 152 cases of Parkinson's disease.
    Mones RJ, Elizan TS, Siegel GJ.
    Neurology; 1970 Apr 15; 20(4):405-6. PubMed ID: 5535050
    [No Abstract] [Full Text] [Related]

  • 11. [Current therapeutics of Parkinson's disease].
    Schott B.
    Cah Med; 1971 Nov 15; 12(14):1175-85. PubMed ID: 5161038
    [No Abstract] [Full Text] [Related]

  • 12. [Abnormal movements observed during treatment of Parkinson's disease with L-dopa].
    Sigwald J, Raymondeaud C.
    Rev Neurol (Paris); 1970 Feb 15; 122(2):103-12. PubMed ID: 4397165
    [No Abstract] [Full Text] [Related]

  • 13. The role of a dihydromorphanthridine derivative in Parkinson's patients treated with L-dopa. A preliminary report.
    Wycis HT.
    Confin Neurol; 1972 Feb 15; 34(2):130-5. PubMed ID: 4666056
    [No Abstract] [Full Text] [Related]

  • 14. Importance and pathogenesis of abnormal movements during L-dopa therapy of Parkinson's disease.
    Barbeau A.
    Neurology; 1970 Apr 15; 20(4):377. PubMed ID: 5534982
    [No Abstract] [Full Text] [Related]

  • 15. Amino acid and dopa levels in plasma and urine from L-dopa-treated patients with Parkinson's disease.
    Hare TA, Vanna S, Beasley B, Chambers R, Vogel WH.
    J Lab Clin Med; 1971 Feb 15; 77(2):319-25. PubMed ID: 5540775
    [No Abstract] [Full Text] [Related]

  • 16. [Treatment of Parkinson's disease with L-dopa].
    Guglielmi L, Vecchi L.
    Clin Ter; 1970 May 15; 53(3):259-69. PubMed ID: 4917328
    [No Abstract] [Full Text] [Related]

  • 17. Levodopa therapy for Parkinson's disease. A first-year experience with outpatients in private practice.
    McFarland HR.
    Mo Med; 1971 Nov 15; 68(11):843-7. PubMed ID: 5096631
    [No Abstract] [Full Text] [Related]

  • 18. [Clinical remarks on the action of intravenous and oral levo-dopa in the treatment of Parkinson's disease (135 cases)].
    Fasano VA, Urciuoli R, Broggi G, Cannella M, Lombard GF.
    Neurochirurgie; 1970 Nov 15; 16(2):171-8. PubMed ID: 5451127
    [No Abstract] [Full Text] [Related]

  • 19. Reappraisal of levodopa therapy for Parkinson's disease. A three-year experience with outpatients in private practice.
    McFarland HR.
    Mo Med; 1974 Sep 15; 71(9):535-7. PubMed ID: 4854038
    [No Abstract] [Full Text] [Related]

  • 20. [Personal experience in the treatment of Parkinson's disease with L-Dopa].
    Figuerido JA, De la Herrán J.
    Rev Clin Esp; 1970 Dec 31; 119(6):555-62. PubMed ID: 5509794
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.